Shionogi & Co., Ltd. 4507.T Stock
Shionogi & Co., Ltd. Price Chart
Shionogi & Co., Ltd. 4507.T Financial and Trading Overview
Shionogi & Co., Ltd. stock price | 7194 JPY |
Previous Close | 6131 JPY |
Open | 6110 JPY |
Bid | 6201 JPY x 0 |
Ask | 6215 JPY x 0 |
Day's Range | 6106 - 6214 JPY |
52 Week Range | 5821 - 7593 JPY |
Volume | 2.11M JPY |
Avg. Volume | 1.27M JPY |
Market Cap | 1.85T JPY |
Beta (5Y Monthly) | 0.538314 |
PE Ratio (TTM) | 9.2652235 |
EPS (TTM) | 528.93 JPY |
Forward Dividend & Yield | 150 (2.44%) |
Ex-Dividend Date | September 28, 2023 |
1y Target Est | 7513.6 JPY |
4507.T Valuation Measures
Enterprise Value | 1.53T JPY |
Trailing P/E | 9.2652235 |
Forward P/E | 11.871693 |
PEG Ratio (5 yr expected) | -35.82 |
Price/Sales (ttm) | 4.329822 |
Price/Book (mrq) | 1.6624913 |
Enterprise Value/Revenue | 3.577 |
Enterprise Value/EBITDA | 9.186 |
Trading Information
Shionogi & Co., Ltd. Stock Price History
Beta (5Y Monthly) | 0.538314 |
52-Week Change | -6.067% |
S&P500 52-Week Change | 20.43% |
52 Week High | 7593 JPY |
52 Week Low | 5821 JPY |
50-Day Moving Average | 6152.6 JPY |
200-Day Moving Average | 6443.44 JPY |
4507.T Share Statistics
Avg. Volume (3 month) | 1.27M JPY |
Avg. Daily Volume (10-Days) | 1.72M JPY |
Shares Outstanding | 297.31M |
Float | 294.2M |
Short Ratio | N/A |
% Held by Insiders | 4.66% |
% Held by Institutions | 52.91% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 135 |
Trailing Annual Dividend Yield | 2.20% |
5 Year Average Dividend Yield | 165.00% |
Payout Ratio | 0.17889999 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | March 31, 2023 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | March 31, 2024 |
Profitability
Profit Margin | 43.34% |
Operating Margin (ttm) | 34.92% |
Gross Margin | 85.41% |
EBITDA Margin | 38.94% |
Management Effectiveness
Return on Assets (ttm) | 7.56% |
Return on Equity (ttm) | 17.44% |
Income Statement
Revenue (ttm) | 426.68B JPY |
Revenue Per Share (ttm) | 1433.25 JPY |
Quarterly Revenue Growth (yoy) | -23.50% |
Gross Profit (ttm) | N/A |
EBITDA | 166.17B JPY |
Net Income Avi to Common (ttm) | 184.97B JPY |
Diluted EPS (ttm) | 670.68 |
Quarterly Earnings Growth (yoy) | -36.89% |
Balance Sheet
Total Cash (mrq) | 309.22B JPY |
Total Cash Per Share (mrq) | 1050.69 JPY |
Total Debt (mrq) | 9.41B JPY |
Total Debt/Equity (mrq) | 0.84 JPY |
Current Ratio (mrq) | 4.946 |
Book Value Per Share (mrq) | 3737.764 |
Cash Flow Statement
Operating Cash Flow (ttm) | 177.87B JPY |
Levered Free Cash Flow (ttm) | 34.2B JPY |
Profile of Shionogi & Co., Ltd.
Country | Japan |
State | N/A |
City | Osaka |
Address | 1-8, Doshomachi 3-chome |
ZIP | 541-0045 |
Phone | 81 6 6202 2161 |
Website | https://www.shionogi.com |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | N/A |
Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Xofluza, an influenza virus drug; and Tivicay, an anti-HIV drug. It also develops Symproic for opioid-induced constipation treatment; S-120083 for Inflammatory pain; S-010887 for Neuropathic pain; S-117957 for Insomnia; sivopixant for Neuropathic pain, and Refractory/unexplained chronic cough; Zuranolone for Depression; SDT-001, Inattentive ADHD pediatric; BPN14770 for Alzheimer's disease; and S-237648 and S-309309 for Obesity. In addition, the company develops ADR-001 for Decompensated liver cirrhosis; S-723595 for NASH; S-588410 for Esophageal and Bladder cancer; S-488210 for Head and neck squamous cell carcinoma; S-588210 for Solid tumor; S-222611 for Malignant tumor; S-770108 for Idiopathic pulmonary; SR-0379 for Cutaneous ulcer; S-005151 for Stroke and Epidermolysis bullosa; S-531011 for Solid tumor; and S-600918 and S-217622 for COVID-19, as well as S-555739 for Control of the aggravation of COVID-19. Further, it offers antibody test kits for COVID-19. Shionogi & Co., Ltd. has collaboration agreements with Nagasaki University, the National Institute of Infectious Diseases, and The Kitasato University to develop antimalarial drugs. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. Shionogi & Co., Ltd. was founded in 1878 and is headquartered in Osaka, Japan.
Q&A For Shionogi & Co., Ltd. Stock
What is a current 4507.T stock price?
Shionogi & Co., Ltd. 4507.T stock price today per share is 7194 JPY.
How to purchase Shionogi & Co., Ltd. stock?
You can buy 4507.T shares on the Tokyo exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Shionogi & Co., Ltd.?
The stock symbol or ticker of Shionogi & Co., Ltd. is 4507.T.
Which industry does the Shionogi & Co., Ltd. company belong to?
The Shionogi & Co., Ltd. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Shionogi & Co., Ltd. have in circulation?
The max supply of Shionogi & Co., Ltd. shares is 286.49M.
What is Shionogi & Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Shionogi & Co., Ltd. PE Ratio is 13.60104400 now.
What was Shionogi & Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Shionogi & Co., Ltd. EPS is 528.93 JPY over the trailing 12 months.
Which sector does the Shionogi & Co., Ltd. company belong to?
The Shionogi & Co., Ltd. sector is Healthcare.
Shionogi & Co., Ltd. 4507.T included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
Nasdaq Developed Select Leaders NQDMSLC | 1260.81 USD — |
0
|
— — | 1243.71 USD — | 1264.94 USD — | — - | — — |
Nikkei 225 N225 | 39142.46 JPY 264.22 USD |
-0.96
|
— — | 38820.95 JPY 262.05 USD | 39170.35 JPY 264.41 USD | — - | — — |
Nikkei 300 N300 | 587.56 JPY 3.97 USD |
-0.57
|
— — | 581.72 JPY 3.93 USD | 588.28 JPY 3.97 USD | — - | — — |
- {{ link.label }} {{link}}